Lipid Nanoparticles for Genome Editing in Hypercholesterolemia

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Leila Arabi Leila Arabi; Jaafari Mahmoud Reza; Arabi Leila

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of North Khorasan University of Medical Sciences Year:2025 | Volume:17 | Issue:1 Page(s): 25-40

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Lipid Nanoparticles for Genome Editing in Hypercholesterolemia

Author(s)

Arabi Leila Arabi" target="_blank">Leila Arabi Leila Arabi | Jaafari Mahmoud Reza | Arabi Leila | Issue Writer Certificate

Keywords

CRISPR-Cas9 technology

Genome Editing

Hyperlipidemia

Lipid Nanoparticles (LNPs)

Abstract

Introduction: Hyperlipidemia is a medical condition that is characterized by elevated blood lipid levels. This condition is often associated with an increased risk of cardiovascular diseases, such as heart attack and stroke. Traditional treatment approaches for Hyperlipidemia include lifestyle modifications, dietary changes, and pharmacotherapy. However, some patients cannot achieve the LDL-C treatment goals, necessitating the development of novel lipid-lowering therapies with improved efficacy and safety profiles. Gene editing, which permanently alters gene expression, can revolutionize disease treatment. The CRISPR/Cas9 system has emerged as the preferred technology among various gene editing approaches due to its high efficiency and relative simplicity. Nowadays, CRISPR-Cas9 technology is frequently used in medicine and many other fields for targeted gene screening and gene therapy. However, challenges remain in the clinical application of CRISPR-Cas9, and a safe and efficient delivery system is required. Method: The search was performed in Scopus, PubMed, and Google Scholar using the following keywords: “Hyperlipidemia,” “CRISPR-Cas9”, “Genome Editing,” “Gene Editing,” “Lipid Nanoparticles,” and “LNPs.” We included all relevant in vitro, in vivo, and clinical trial studies published until November 2024. Results: It has been indicated that the use of lipid nanoparticles (LNPs) as delivery vehicles is promising. The LNPs enhance the stability of the CRISPR/Cas9 system and offer advantages, such as ease of production and high versatility, making them an ideal carrier with great potential. Conclusion: This review provides an overview of the hopeful technology and the latest advances in the development of dyslipidemia treatments.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans